JointWave™ vs. PRP Injections for Chiropractors: Better Outcomes. Zero Needles. Faster ROI.

Chiropractor providing non-invasive JointWave high-intensity shockwave therapy to a patient in a modern clinic

If your patients struggle with chronic tendinopathy, plantar fasciitis, joint stiffness, or stubborn soft-tissue pain, you already know the challenge: they want meaningful results without surgery, medication, or a complicated recovery process.

That is why many clinics compare high-intensity shockwave therapy with platelet-rich plasma, or PRP, injections.

Both approaches aim to stimulate the body’s natural healing response. However, they create very different experiences for your patients: and very different business models for your practice.

JointWave™ gives your clinic a needle-free, cash-based treatment option that is easier to accept, easier to implement, and built for long-term utilization.

Better Care. Easier Acceptance. Stronger Margins.

PRP uses a patient’s own blood. A clinician draws the blood, processes it: typically with a centrifuge: and injects the concentrated platelets into or around the affected tissue.

JointWave uses acoustic energy delivered through the skin. The treatment head applies high-intensity shockwave energy to targeted soft tissue, joints, and tendons without a blood draw or injection.

That difference affects nearly every part of the patient journey.

Comparison of PRP preparation equipment and a non-invasive shockwave therapy applicator

With JointWave, your clinic can offer:

  • No needles
  • No blood draw
  • No injection-related infection risk
  • No anesthesia or sterile injection setup
  • No formal downtime for most patients
  • Minimal consumables
  • A treatment experience that complements chiropractic care

Patients often accept a treatment faster when they do not have to overcome anxiety about needles, blood, or post-injection soreness. That creates a simpler conversation for your team and a lower barrier to starting care.

Targeted Energy. Natural Healing. No Needles.

High-intensity shockwave therapy uses mechanical acoustic energy to stimulate a biological response in the treatment area.

The energy can support:

  • Improved local circulation
  • Neovascularization
  • Modulation of inflammation
  • Collagen remodeling
  • Tissue regeneration
  • Reduced pain and stiffness

This process, commonly described as mechanotransduction, allows cells to respond to mechanical stimulation. The goal is not to inject a substance into the body. The goal is to encourage the body to restart a healing process that may have stalled.

The International Society for Medical Shockwave Treatment guidelines identify shockwave therapy as a non-invasive treatment approach used across several musculoskeletal conditions, including plantar fasciitis, Achilles tendinopathy, lateral epicondylopathy, patellar tendinopathy, and myofascial pain.

Close-up of a clinician applying a shockwave treatment head to a patient's lower leg

PRP works through a different biological mechanism. Platelets contain growth factors that may support tissue repair, but outcomes vary based on the patient, condition, platelet concentration, preparation method, injection technique, and number of treatments.

That variability matters when you build a predictable clinical service line.

Comparable Results. Fewer Barriers. Better Fit.

The clinical evidence does not support claiming that one therapy wins in every condition or every patient. Treatment selection should depend on the diagnosis, tissue involved, patient history, contraindications, and your local scope-of-practice requirements.

However, research shows that shockwave therapy can produce outcomes comparable to PRP for several chronic tendinopathies, particularly when clinicians pair treatment with progressive loading, rehabilitation, and patient education.

For example:

  • A randomized trial comparing PRP and focused shockwave therapy for patellar tendinopathy found meaningful improvement with both approaches.
  • A 2024 randomized controlled trial found that PRP combined with shockwave therapy produced faster pain reduction than PRP alone at one month, while both groups maintained functional improvement through one year.
  • The ISMST guidelines identify shockwave therapy as a well-established non-invasive option for several tendon and soft-tissue conditions.
  • Research on Achilles tendinopathy supports combining shockwave therapy with progressive eccentric loading.

The practical takeaway is simple: PRP may help selected patients, but it is not automatically superior to shockwave therapy.

For many chronic conditions, JointWave can offer a comparable long-term care pathway without the preparation, invasiveness, and operational complexity of injections.

Review the published comparison research in this randomized controlled trial on PRP and shockwave therapy for patellar tendinopathy.

Zero Downtime. Faster Patient Decisions. Smoother Visits.

PRP creates a procedure-centered visit. The patient must prepare for a blood draw, tolerate an injection, and follow post-injection instructions. Some patients experience soreness or activity restrictions afterward.

JointWave creates a treatment-centered visit.

Your team applies coupling gel, positions the treatment head, and delivers the prescribed acoustic energy to the target area. Patients can typically return to their regular daily activities immediately, although temporary local soreness can occur.

That difference supports faster decision-making.

A patient may hesitate when the care plan includes:

  • A blood draw
  • A centrifuge
  • A sterile field
  • One or more injections
  • A medical referral
  • Post-injection restrictions
  • Additional recovery time

The same patient may respond more positively to:

“We can provide a non-invasive treatment in the office without needles, blood draws, or surgery.”

Faster acceptance improves scheduling, plan-of-care enrollment, and patient follow-through.

Higher Margins. Lower Overhead. Faster ROI.

PRP can support a premium cash-based service, but it also carries additional operating requirements. Depending on your model and jurisdiction, you may need a medical partner, specialized injection training, blood-processing equipment, sterile supplies, additional compliance procedures, and expanded malpractice considerations.

JointWave supports a simpler cash-based model for chiropractic practices.

You can build treatment packages around:

  • A clinical assessment
  • A defined shockwave protocol
  • Chiropractic adjustments
  • Corrective exercise
  • Mobility work
  • Progressive loading
  • Reassessment and outcome tracking

Because JointWave treatments do not require blood products or injection supplies, your variable costs stay low. That helps protect your margin as patient volume grows.

A typical shockwave visit also fits naturally into an existing chiropractic schedule. Your team can deliver a focused treatment, reinforce the care plan, and move the patient toward the next step without requiring a separate procedure room or complex preparation process.

Read more about the ROI of high-intensity shockwave therapy for chiropractic clinics.

Superior Treatment Heads. Longer Equipment Life. Better ROI.

Your return on investment depends on more than the purchase price of a device. It also depends on reliability, utilization, maintenance, and treatment-head longevity.

JointWave™ treatment heads are technologically superior and built to outlast major competitors. JointWave systems are engineered for high-volume clinical use, with treatment heads designed to maintain performance for 400,000+ clicks.

That creates three important advantages:

  • Fewer replacements: Reduce the long-term cost of ownership.
  • Consistent output: Deliver dependable treatment performance over time.
  • Higher lifetime value: Keep more revenue in your clinic as utilization increases.

A lower-priced device may appear attractive at the beginning. But frequent treatment-head replacement, inconsistent performance, or downtime can quickly reduce the value of that investment.

Durability protects your margins long after the initial purchase.

Chiropractic clinic leaders reviewing growth metrics beside a shockwave therapy system

Easier Training. Better Delegation. Stronger Implementation.

A new technology only produces results when your team uses it consistently.

JointWave is designed to help your practice move from installation to patient care without unnecessary friction. Your clinic receives:

  • ✅ White-glove installation
  • ✅ Staff training
  • ✅ Treatment guidance
  • ✅ Patient education materials
  • ✅ Marketing support
  • ✅ Help integrating the service into your existing care plans

Your team can learn how to identify appropriate candidates, explain the non-invasive treatment experience, and position JointWave as a complement to chiropractic care: not a replacement for clinical judgment.

The JointWave Framework helps your clinic connect clinical delivery with patient communication and practice growth.

A Better In-Office Alternative. A Lower-Risk Decision.

PRP will remain appropriate for selected patients and specialized clinical situations. Your practice can also collaborate with medical providers when a patient requires injection-based care.

But you do not need to build your primary regenerative service around needles, blood draws, and outside referrals.

JointWave gives you an in-office option that supports:

  • Better patient access
  • Non-invasive care
  • Minimal downtime
  • Predictable treatment delivery
  • Lower operating complexity
  • Cash-based revenue
  • Long-term equipment ROI

Most importantly, you can test the model before making a long-term commitment.

Try JointWave Risk-Free. See the Difference in Your Clinic.

JointWave offers a 30-day risk-free, no-obligation in-office trial.

You can install the system, train your team, introduce the service to appropriate patients, and evaluate how it fits your clinical and business goals.

Do not guess whether shockwave therapy belongs in your practice. Test it in your own treatment room.

Visit jointwavetrial.com to start your risk-free 30-day JointWave™ trial.

Clinical outcomes vary by patient, condition, protocol, and provider experience. Always evaluate patients appropriately, follow manufacturer guidance, comply with applicable laws and scope-of-practice requirements, and refer when a condition requires care outside your clinical authority.